Galmed Pharmaceuticals Ltd (GLMD) — Long-term Investment Intensity
Galmed Pharmaceuticals Ltd (GLMD) has a Long-term Investment Intensity of 7.4% as of September 2025. Long-term investments of $1.59 Million represent 7.4% of total assets of $21.58 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore GLMD cash flow metrics to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Galmed Pharmaceuticals Ltd Long-term Investment Intensity (2022–2024)
This chart shows how Galmed Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the intensity stands at 7.4%, reflecting long-term investments of $1.59 Million against total assets of $21.58 Million USD. Explore Galmed Pharmaceuticals Ltd (GLMD) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Galmed Pharmaceuticals Ltd (2022–2024)
The table below presents the year-by-year Long-term Investment Intensity for Galmed Pharmaceuticals Ltd from 2022 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Galmed Pharmaceuticals Ltd worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 11.5% | $2.12 Million | $18.50 Million | ▼ -8.2 pp |
| 2023 | 19.6% | $3.27 Million | $16.63 Million | ▲ +10.6 pp |
| 2022 | 9.1% | $1.50 Million | $16.56 Million | — |